Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann C Collier

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 2011
Complex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropionBrian J Kirby, Ann C Collier, Evan D Kharasch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2015
Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s ResultsJulie B Dumond, Joseph Rigdon, Katie Mollan, et al.
AIDS Research and Human Retroviruses|April 17, 2019
Acceptability of Cell and Gene Therapy for Curing HIV Infection Among People Living with HIV in the Northwestern United States: A Qualitative StudyKarine Dubé, Jane Simoni, Michael Louella, et al.
The Journal of Infectious Diseases|January 28, 2004
Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 diseaseUma Malhotra, Ronald J Bosch, Ellen Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human dataPeng Hsiao, Lucy Sasongko, Jeanne M Link, et al.
HIV Clinical Trials|August 30, 2008
AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristicsMarlene Smurzynski, Ann C Collier, Susan L Koletar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapyLu Zheng, Babafemi Taiwo, Rajesh T Gandhi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humansMark Muzi, David A Mankoff, Jeanne M Link, et al.
Antiviral Therapy|April 24, 2015
How often does treatment of primary HIV lead to post-treatment control?Janine Maenza, Kenneth Tapia, Sarah Holte, et al.
AIDS (London, England)|July 4, 2006
Abacavir hypersensitivity reaction in primary HIV infectionJoanne Stekler, Janine Maenza, Claire Stevens, et al.
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 2011
Complex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropionBrian J Kirby, Ann C Collier, Evan D Kharasch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2015
Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s ResultsJulie B Dumond, Joseph Rigdon, Katie Mollan, et al.
AIDS Research and Human Retroviruses|April 17, 2019
Acceptability of Cell and Gene Therapy for Curing HIV Infection Among People Living with HIV in the Northwestern United States: A Qualitative StudyKarine Dubé, Jane Simoni, Michael Louella, et al.
The Journal of Infectious Diseases|January 28, 2004
Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 diseaseUma Malhotra, Ronald J Bosch, Ellen Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human dataPeng Hsiao, Lucy Sasongko, Jeanne M Link, et al.
HIV Clinical Trials|August 30, 2008
AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristicsMarlene Smurzynski, Ann C Collier, Susan L Koletar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapyLu Zheng, Babafemi Taiwo, Rajesh T Gandhi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humansMark Muzi, David A Mankoff, Jeanne M Link, et al.
Antiviral Therapy|April 24, 2015
How often does treatment of primary HIV lead to post-treatment control?Janine Maenza, Kenneth Tapia, Sarah Holte, et al.
AIDS (London, England)|July 4, 2006
Abacavir hypersensitivity reaction in primary HIV infectionJoanne Stekler, Janine Maenza, Claire Stevens, et al.
Pageof 19